Connect your AI

NewAmsterdam Pharma Company NAMS CapEx

CapEx at other companies

Merck & Co.MRK

$991M-25.4%

AmgenAMGN

$712M+73.2%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

Eli LillyLLY

$2.33B+54.0%

Denali Therapeutics Inc.DNLI

$2.47M-51.4%

Other financials

Income statement

Revenue$3.0M+2.1%

Operating income-$58.4M+15.2%

Net income-$48.4M-22.6%

EPS (diluted)-$0.40-17.6%

Balance sheet

Cash & equivalents$457.6M-38.9%

Total debt$23.0K-94.1%

Total equity$665.2M-14.4%

Total assets$732.6M-10.5%

Cash flow

Operating cash flow-$30.6M+16.1%

Free cash flow-$30.6M+16.0%

Valuation

Market cap$3.67B+63.7%

Profitability

Operating margin-953.6%-3,536pp

Net margin-942.8%-3,477pp

FCF margin-630.1%-6,324pp

Returns & leverage

Return on equity-29.5%-1.8pp

Current ratio9.8×-10.2×

Where this comes from

Reported directly by NewAmsterdam Pharma Company in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NewAmsterdam Pharma Company's capex?: NewAmsterdam Pharma Company (NAMS) reported capex of $38K in Q1 2026.
How has NewAmsterdam Pharma Company's capex changed year-over-year?: NewAmsterdam Pharma Company's capex increased by 137.5% year-over-year, from $16K to $38K.
What is the long-term trend for NewAmsterdam Pharma Company's capex?: Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's capex has grown at a 78.9% compound annual growth rate (CAGR), from $24K to $246K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.